Kelly Gold bought $11k of CAMP
Chief Financial Officer at Camp4 Therapeutics Corp. 6,551 shares at an average of $1.65, traded Aug 3, 2026, filed Aug 5, 2026.
Score components
- +22RoleCFO
- 0Trade size$11k at market
- +3Relative to holdingsHoldings up 10%
- +8Price context41% below the 52-week high
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-053511, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | POpen-market purchase Common Stock | +6,551 | $1.65 | $11k | 74,428 | Aug 5, 2026 |
Related signals
Other insiders at Camp4 Therapeutics Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 44Moderate | CAMPbuy Camp4 Therapeutics Corp | Kelly Gold Chief Financial Officer | $40k 10,000 shares | - | |
| 53Moderate | Camp4 Therapeutics Corp | Andrew J. Schwab director | $1.6M 400,000 shares | -16% | |
| 23Weak | Camp4 Therapeutics Corp | Andrew J. Schwab director | $45 10 shares | -0% | |
| 46Moderate | Camp4 Therapeutics Corp | Andrew J. Schwab director | $880k 191,865 shares | -7% | |
| 43Moderate | Camp4 Therapeutics Corp | Daniel Tardiff Chief Scientific Officer | $8,273 1,738 shares | -100% | |
| 48Moderate | Camp4 Therapeutics Corp | Josh Mandel-Brehm Chief Executive Officer | $11k 6,551 shares | +2% | |
| 48Moderate | Camp4 Therapeutics Corp | Yuri Maricich Chief Medical Officer | $11k 6,551 shares | +108% | |
| 46Moderate | Camp4 Therapeutics Corp | Richard A Young director | $27k 16,378 shares | +10% | |
| 63Notable | Camp4 Therapeutics Corp | 5AM Partners VI, LLC owner | $4.5M 2,941,176 shares | - | |
| 73Notable | Camp4 Therapeutics Corp | Amir Nashat director, owner | $2.0M 1,307,189 shares | +82% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.